Loading...

NBC features Toca 511 delivery in patient with glioblastoma at UC San Diego Moores Cancer Center

3,611 views

Loading...

Loading...

Transcript

The interactive transcript could not be loaded.

Loading...

Loading...

Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Aug 8, 2013

A NBC reporter interviews patient Berm, who was given a prognosis of six months after being diagnosed with recurrent brain cancer, but two years later was still doing well. He shares more about his quality of life and how the treatment makes him feel. Dr. David Piccioni, neuro-oncologist at UC San Diego also explains how the viral therapy is designed to work.

Learn more about Tocagen’s clinical trials here: http://tocagen.com/patients/clinical-...
Subscribe to Tocagen: https://goo.gl/EGb8E3
Like us on Facebook: https://www.facebook.com/Tocagen/
Follow us on Twitter: @Tocagen

Loading...

When autoplay is enabled, a suggested video will automatically play next.

Up next


to add this to Watch Later

Add to

Loading playlists...